Nicolas Sireau - The use of psilocybin to treat OCD & future OCD treatments

Psilocybin therapy is investigated as a potential treatment for Obsessive-Compulsive Disorder, a condition that remains significantly underfunded in medical research despite its high personal and economic burden. Patients suffering from this condition often struggle with inflexible thought patterns and standard psychiatric interventions like SSRIs or Exposure Response Prevention, necessitating the exploration of novel psychedelic treatments to improve clinical outcomes and cognitive flexibility. Active research projects involving psilocybin, including feasibility studies at Imperial College London, focus on assessing safety and signs of efficacy for OCD. Researchers aim to understand how psilocybin interacts with relevant neurobiological pathways, such as 5-HT2A receptors, and its potential effects on glutamate levels in the brain to challenge the rigidity of obsessive behaviors.